Literature DB >> 1386337

The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci.

A Steinkasserer1, N K Spurr, S Cox, P Jeggo, R B Sim.   

Abstract

The IL-1 receptor antagonist (IL-1RN) is a protein that binds to IL-1 receptors and inhibits the binding of IL-1 alpha and IL-1 beta. As a consequence, the biological activity of these two cytokines is neutralized in physiological and pathophysiological immune and inflammatory responses. In this study, using a panel of somatic rodent-human cell hybrids, we show that the gene for the human interleukin-1 receptor antagonist (IL1RN) maps to the long arm of chromosome 2. Previously, we described a length variation polymorphism within the second intron of the IL-1RN gene (Steinkasserer et al., 1991, Nucleic Acids Res. 19: 5095). Segregation of this, together with an IL-1 alpha polymorphism, was followed in a panel of five CEPH families. Linkage analysis permitted the mapping of the IL-1RN gene to band q14-q21 in the region for the IL-1 alpha and IL-1 beta loci. This study supports the view that an early gene duplication event resulted in the creation of an interleukin-1 gene family.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1386337     DOI: 10.1016/0888-7543(92)90137-h

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  35 in total

1.  Genetics of the bone response to bisphosphonate treatments.

Authors:  Francesco Massart; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2009-01

2.  Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers.

Authors:  L Joos; L McIntyre; J Ruan; J E Connett; N R Anthonisen; T D Weir; P D Paré; A J Sandford
Journal:  Thorax       Date:  2001-11       Impact factor: 9.139

3.  Relations between interleukin-1, its receptor antagonist gene polymorphism, and bone mineral density in postmenopausal Korean women.

Authors:  Jung Gu Kim; Kyung Sil Lim; Seung-Yup Ku; Seok Hyun Kim; Young Min Choi; Shin Yong Moon
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

Review 4.  Genetic polymorphisms of cytokine genes in type 2 diabetes mellitus.

Authors:  Monisha Banerjee; Madhukar Saxena
Journal:  World J Diabetes       Date:  2014-08-15

Review 5.  Biological role of interleukin 1 receptor antagonist isoforms.

Authors:  W P Arend; C J Guthridge
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

6.  Sustained delivery of IL-1Ra from pluronic F127-based thermosensitive gel prolongs its therapeutic potentials.

Authors:  Muhammad Sajid Hamid Akash; Kanwal Rehman; Ni Li; Jian-Qing Gao; Hongying Sun; Shuqing Chen
Journal:  Pharm Res       Date:  2012-08-21       Impact factor: 4.200

7.  Interleukin-10 gene -627 allele variants, not interleukin-I beta gene and receptor antagonist gene polymorphisms, are associated with atopic bronchial asthma.

Authors:  Liang-Wen Hang; Te-Chun Hsia; Wen-Chi Chen; Huey-Yi Chen; Jeffrey J P Tsai; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

8.  Association of interleukin-1 beta (-511C/T) polymorphisms with osteoporosis in postmenopausal women.

Authors:  Tai-Hung Chao; Hsing-Ning Yu; Chi-Chuan Huang; Wen-Shen Liu; Ya-Wen Tsai; Wen-Tung Wu
Journal:  Ann Saudi Med       Date:  2010 Nov-Dec       Impact factor: 1.526

9.  Stroke, IL-1ra, IL1RN, infection and outcome.

Authors:  Kyra J Becker; Dorender Dankwa; Richard Lee; Juliane Schulze; Dannielle Zierath; Patricia Tanzi; Kevin Cain; Alexander Dressel; Dean Shibata; Jonathan Weinstein
Journal:  Neurocrit Care       Date:  2014-08       Impact factor: 3.210

10.  Interleukin-1 receptor antagonist gene polymorphism, vaginal interleukin-1 receptor antagonist concentrations, and vaginal ureaplasma urealyticum colonization in pregnant women.

Authors:  Parrin T Barton; Stefan Gerber; Daniel W Skupski; Steven S Witkin
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.